PRCT Q2 2023 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$33M+98.3% YoY

Gross Profit

$18M55.7% margin

Operating Income

-$26M-77.4% margin

Net Income

-$25M-76.4% margin

EPS (Diluted)

$-0.56

QoQ Revenue Growth

+35.6%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$34M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$272M

Total Liabilities

$117M

Stockholders' Equity

$156M

Cash & Equivalents

$150M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$17M	+98.3%
Gross Profit	$18M	$8M	+117.2%
Operating Income	-$26M	-$18M	-43.4%
Net Income	-$25M	-$19M	-31.8%

Geographic Segments

UNITED STATES

$15M90%

Outside the United States

$2M10%